These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10449871)

  • 1. Uremic ultrafiltrate inhibits platelet-activating factor synthesis.
    Wratten ML; Tetta C; De Smet R; Neri R; Sereni L; Camussi G; Vanholder R
    Blood Purif; 1999; 17(2-3):134-41. PubMed ID: 10449871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of uremic ultrafiltrate on the regulation of the parathyroid cell cycle by calcitriol.
    Canalejo A; Almadén Y; De Smet R; Glorieux G; Garfia B; Luque F; Vanholder R; Rodríguez M
    Kidney Int; 2003 Feb; 63(2):732-7. PubMed ID: 12631141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of decreased calcitriol degradation in renal failure.
    Hsu CH; Patel SR; Young EW
    Am J Physiol; 1992 Feb; 262(2 Pt 2):F192-8. PubMed ID: 1311521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat.
    Anderstam B; Mamoun AH; Södersten P; Bergström J
    J Am Soc Nephrol; 1996 Nov; 7(11):2453-60. PubMed ID: 8959639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism.
    Hsu CH; Vanholder R; Patel S; De Smet RR; Sandra P; Ringoir SM
    Kidney Int; 1991 Nov; 40(5):868-73. PubMed ID: 1762291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study by means of high-performance liquid chromatography of solutes that decrease theophylline/protein binding in the serum of uremic patients.
    De Smet R; Vogeleere P; Van Kaer J; Lameire N; Vanholder R
    J Chromatogr A; 1999 Jun; 847(1-2):141-53. PubMed ID: 10431358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate.
    Patel SR; Ke HQ; Vanholder R; Hsu CH
    Kidney Int; 1994 Jul; 46(1):129-33. PubMed ID: 7933830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension.
    Noris M; Benigni A; Boccardo P; Aiello S; Gaspari F; Todeschini M; Figliuzzi M; Remuzzi G
    Kidney Int; 1993 Aug; 44(2):445-50. PubMed ID: 8377388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM; van Landschoot N; de Smet R
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-Cresol, a uremic compound, enhances the uptake of aluminum in hepatocytes.
    Abreo K; Sella M; Gautreaux S; De Smet R; Vogeleere P; Ringoir S; Vanholder R
    J Am Soc Nephrol; 1997 Jun; 8(6):935-42. PubMed ID: 9189861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of uremic solutes in the cerebrospinal fluid in experimental acute renal failure.
    Mair RD; Nguyen H; Huang TT; Plummer NS; Sirich TL; Meyer TW
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F296-F302. PubMed ID: 31141401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of uremic ultrafiltrate using high resolution gas chromatography-mass spectrometry - identification of 6 polyphenols.
    Niwa T; Maeda K; Ohki T; Saito A; Kobayashi S; Asada H; Kobayashi K
    Clin Chim Acta; 1980 Nov; 108(1):113-9. PubMed ID: 7449132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmonella typhimurium porins stimulate platelet-activating factor synthesis by human polymorphonuclear neutrophils.
    Tufano MA; Tetta C; Biancone L; Iorio EL; Baroni A; Giovane A; Camussi G
    J Immunol; 1992 Aug; 149(3):1023-30. PubMed ID: 1321849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz HAART regimen.
    Chini M; Tsoupras AB; Mangafas N; Tsogas N; Papakonstantinou VD; Fragopoulou E; Antonopoulou S; Gargalianos P; Demopoulos CA; Lazanas MC
    Int J Immunopathol Pharmacol; 2012; 25(1):247-58. PubMed ID: 22507337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cytotoxic properties of plasma fractions from uremic patients.
    Delaporte C; Gros F; Jonsson C; Bergström J
    Artif Organs; 1981; 4 Suppl():68-70. PubMed ID: 7295099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of uremic "middle molecular" fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography.
    Schoots AC; Mikkers FE; Claessens HA; De Smet R; Van Landschoot N; Ringoir SM
    Clin Chem; 1982 Jan; 28(1):45-9. PubMed ID: 7055936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.